speb/financial-data huggingface dataset:
Financial ratios for MARI.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -33823.529411764706
Operating income: -5014705.882352941
Net income: -1588970.588235294
Capital expenditures: 4169852.9411764704
Operating cash flow: -2210294.117647059
Depreciation & amortization: 33823.529411764706
Net tangible assets: 61958823.52941176
Owner earnings: -5725000
Return on net tangible assets (%): -9.240007595177063
Buffett classification: The Gruesome
Stock price: 2.3676470588235294
Shares outstanding: 134980260
Book value: 61958823.52941176
P/B ratio: 5.15803234121333
Market cap (USD): 319585615.5882353
Debt to equity: 0
Current ratio: 34.698752228164
Quick ratio: 34.698752228164
Free cash flow (dilution-adjusted): -21116911.76470588
Buyback yield (%): 0
Retained earnings: -102353676.47058822
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.093610557296117
Rule of 40 score: 0
Financial ratios for MARI.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -40909.090909090904
Operating income: -4464393.939393939
Net income: -5388636.363636363
Capital expenditures: 1538636.3636363635
Operating cash flow: -2369696.9696969697
Depreciation & amortization: 40909.090909090904
Net tangible assets: 71511363.63636364
Owner earnings: -6886363.636363636
Return on net tangible assets (%): -9.62974733831241
Buffett classification: The Gruesome
Stock price: 2.5984848484848486
Shares outstanding: 134980260
Book value: 71511363.63636363
P/B ratio: 4.904733214682982
Market cap (USD): 350744160.4545455
Debt to equity: 0.0013560040256369512
Current ratio: 20.38415159345392
Quick ratio: 20.38415159345392
Free cash flow (dilution-adjusted): -11449242.424242424
Buyback yield (%): 0
Retained earnings: -110843939.39393939
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.240072852029903
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.97037037037037
Shares outstanding: 134980260
Market cap (USD): 400941364.88888884
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2024-12-31
Capital expenditures: 2933566.433566434
Buffett classification: The Gruesome
Stock price: 3.6993006993006996
Shares outstanding: 134980260
Market cap (USD): 499332570.2097902
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MARI.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -120979.02097902098
Operating income: -10079020.97902098
Net income: -9616783.216783218
Capital expenditures: 376923.07692307694
Operating cash flow: -4011888.111888112
Depreciation & amortization: 120979.02097902098
Net tangible assets: 76627272.72727273
Owner earnings: -9872727.272727273
Return on net tangible assets (%): -12.88409063945901
Buffett classification: The Gruesome
Stock price: 3.6993006993006996
Shares outstanding: 134980260
Book value: 76627272.72727273
P/B ratio: 6.516381862982194
Market cap (USD): 499332570.2097902
Debt to equity: 0.00041067012237969646
Current ratio: 9.079500891265598
Quick ratio: 9.079500891265598
Free cash flow (dilution-adjusted): -15753846.153846156
Buyback yield (%): 0
Retained earnings: -111934265.73426574
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.1533077196857
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -42657.34265734266
Operating income: -1751748.2517482517
Net income: -1572727.2727272727
Capital expenditures: 8391.608391608392
Operating cash flow: -1735664.3356643356
Depreciation & amortization: 42657.34265734266
Net tangible assets: 75502797.2027972
Owner earnings: -1538461.5384615385
Return on net tangible assets (%): -2.037621909992683
Buffett classification: The Gruesome
Stock price: 3.6503496503496504
Shares outstanding: 134980260
Book value: 75502797.20279722
P/B ratio: 6.525919080476802
Market cap (USD): 492725144.8951049
Debt to equity: 0.0002315479443173503
Current ratio: 8.523715415019762
Quick ratio: 8.523715415019762
Free cash flow (dilution-adjusted): -6279720.27972028
Buyback yield (%): 0
Retained earnings: -113506993.00699301
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.32011040205985
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -43065.69343065693
Operating income: -3548175.182481752
Net income: -2854014.598540146
Capital expenditures: 9489.05109489051
Operating cash flow: -2210948.905109489
Depreciation & amortization: 43065.69343065693
Net tangible assets: 89662043.79562043
Owner earnings: -2820437.9562043794
Return on net tangible assets (%): -3.1456320164119935
Buffett classification: The Gruesome
Stock price: 5.255474452554744
Shares outstanding: 134980260
Book value: 89662043.79562044
P/B ratio: 7.911768213160529
Market cap (USD): 709385308.0291971
Debt to equity: 3.256347843076597e-05
Current ratio: 16.290919952210274
Quick ratio: 16.290919952210274
Free cash flow (dilution-adjusted): -6978102.189781021
Buyback yield (%): 0
Retained earnings: -121332846.71532845
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.9572767162988347
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -13669.06474820144
Operating income: -7238129.496402878
Net income: -7692086.330935252
Capital expenditures: 846043.165467626
Operating cash flow: -771223.0215827338
Depreciation & amortization: 15827.338129496404
Net tangible assets: 131187769.78417267
Owner earnings: -8522302.158273382
Return on net tangible assets (%): -6.496262702151345
Buffett classification: The Gruesome
Stock price: 8.280575539568346
Shares outstanding: 134980260
Book value: 131187769.78417267
P/B ratio: 8.519957623484379
Market cap (USD): 1117714239.2805758
Debt to equity: 2.1935717380217275e-05
Current ratio: 20.305996924654025
Quick ratio: 20.305996924654025
Free cash flow (dilution-adjusted): -11938129.496402878
Buyback yield (%): 0
Retained earnings: -127279136.6906475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.51738131405915
Rule of 40 score: 0
Financial ratios for MARI.TO — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -48175.18248175182
Operating income: -8556934.306569342
Net income: -6883941.605839415
Capital expenditures: 1477372.2627737224
Operating cash flow: -8926277.372262772
Depreciation & amortization: 45985.40145985401
Net tangible assets: 126231386.86131386
Owner earnings: -8315328.467153284
Return on net tangible assets (%): -6.587369967097844
Buffett classification: The Gruesome
Stock price: 8.124087591240876
Shares outstanding: 134980260
Book value: 126231386.86131386
P/B ratio: 8.687153667520542
Market cap (USD): 1096591455.3284671
Debt to equity: 0.005400810699850235
Current ratio: 14.025390218522373
Quick ratio: 14.025390218522373
Free cash flow (dilution-adjusted): -7900000
Buyback yield (%): 0
Retained earnings: -136021167.88321167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.748021298028493
Rule of 40 score: 0
Financial ratios for MARI.TO — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -149635.03649635037
Operating income: -21277372.262773722
Net income: -19184671.532846715
Capital expenditures: 2354014.598540146
Operating cash flow: -13731386.861313868
Depreciation & amortization: 149635.03649635037
Net tangible assets: 126231386.86131386
Owner earnings: -21389051.094890513
Return on net tangible assets (%): -16.944320764208936
Buffett classification: The Gruesome
Stock price: 8.124087591240876
Shares outstanding: 134980260
Book value: 126231386.86131386
P/B ratio: 8.687153667520542
Market cap (USD): 1096591455.3284671
Debt to equity: 0.005400810699850235
Current ratio: 14.025390218522373
Quick ratio: 14.025390218522373
Free cash flow (dilution-adjusted): -33545255.47445255
Buyback yield (%): 0
Retained earnings: -136021167.88321167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.779392718376744
Rule of 40 score: 0
Financial ratios for MEM.AX — annual report dated 2021-06-30
Operating income: -1474435.3383458646
Net income: -1117618.045112782
Capital expenditures: 88776.6917293233
Depreciation & amortization: 195102.25563909774
Net tangible assets: 237387.96992481203
Owner earnings: -1011292.4812030075
Return on net tangible assets (%): -426.0083110038451
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 3087233743
Book value: 6471421.052631578
P/B ratio: 21.521347716216706
Market cap (USD): 139273702.6917293
Debt to equity: 0.6224775444144818
Current ratio: 4.3050939439172495
Quick ratio: 4.166452118887869
Interest coverage ratio: -77.39054422037177
Free cash flow (dilution-adjusted): -2225102.2556390977
Buyback yield (%): 0.003308247506846887
Retained earnings: -30952949.62406015
Capitalized R&D asset: 350574.4360902255
ROCI (R&D-adjusted, %): -11.628793980923916
Rule of 40 score: 0
Financial ratios for MEM.AX — annual report dated 2022-06-30
Total revenue: 18722.758620689656
Gross profit: 5684.827586206897
Operating income: -1885007.5862068967
Net income: -1435837.2413793104
Capital expenditures: 1975.1724137931035
Depreciation & amortization: 84973.10344827587
Net tangible assets: -1401544.8275862068
Owner earnings: -1352839.3103448276
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 3087233743
Book value: 5273471.72413793
P/B ratio: 16.149715638484054
Market cap (USD): 85165068.7724138
Debt to equity: 0.7274068224897714
Current ratio: 0.4468847054863356
Quick ratio: 0.4277007494965098
Interest coverage ratio: -6.038234079074977
COGS to revenue (%): 69.63680565787534
R&D to revenue (%): 4012.693384411375
SG&A to revenue (%): 4029.033446294387
Free cash flow (dilution-adjusted): -1800893.103448276
Buyback yield (%): 0.024721970007309548
Retained earnings: -29496973.79310345
Inventory turnover: 0.2170942330217496
Capitalized R&D asset: 986171.7687321752
ROCI (R&D-adjusted, %): -19.76487416545295
FCF margin (%): -9618.738028584057
Rule of 40 score: -9618.738028584057
Financial ratios for MEM.AX — annual report dated 2023-06-30
Total revenue: 10179.470198675497
Gross profit: 6106.622516556291
Operating income: -2406501.986754967
Net income: -2253389.40397351
Capital expenditures: 4103.973509933775
Depreciation & amortization: 405853.64238410594
Net tangible assets: -1927182.119205298
Owner earnings: -1851639.735099338
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 3087233743
Book value: 4890522.516556292
P/B ratio: 4.180587351749003
Market cap (USD): 20445256.57615894
Debt to equity: 0.8628915855495065
Current ratio: 0.4039183509538122
Quick ratio: 0.3804264946811654
Interest coverage ratio: -11.4712179230184
COGS to revenue (%): 40.01040921215275
R&D to revenue (%): 9558.870600481425
SG&A to revenue (%): 4775.121982954915
Free cash flow (dilution-adjusted): -2138212.582781457
Buyback yield (%): 0.9185083592810419
Retained earnings: -30578298.01324503
Inventory turnover: 0.04702338170752221
Capitalized R&D asset: 1592094.1687053898
ROCI (R&D-adjusted, %): -27.892224003536125
Rosenberg metric: 0.0005614299041888783
FCF margin (%): -21005.146054258017
Revenue growth (%): -45.63050026492018
Rule of 40 score: -21050.776554522938
Financial ratios for MEM.AX — annual report dated 2024-06-30
Total revenue: 40000
Gross profit: 1070.6666666666667
Operating income: -3492486.6666666665
Net income: -2961347.3333333335
Capital expenditures: 3030
Depreciation & amortization: 478108.6666666667
Net tangible assets: -2168004
Owner earnings: -2486268.666666667
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 3087233743
Book value: 4558503.333333334
P/B ratio: 4.514981515131794
Market cap (USD): 20581558.28666667
Debt to equity: 0.7033301134656037
Current ratio: 0.308059364354665
Quick ratio: 0.2767005794754611
Interest coverage ratio: -16.437345666422974
COGS to revenue (%): 97.32333333333334
R&D to revenue (%): 3564.3433333333332
SG&A to revenue (%): 2260.5633333333335
Free cash flow (dilution-adjusted): -2579754.6666666665
Buyback yield (%): 1.1919214113098657
Retained earnings: -33620057.333333336
Inventory turnover: 0.3544163970842614
Capitalized R&D asset: 2325600.4065463953
ROCI (R&D-adjusted, %): -43.83856360301841
Rosenberg metric: -0.005175474298086926
FCF margin (%): -6449.386666666666
Revenue growth (%): 292.94775876650834
Rule of 40 score: -6156.438907900158
Financial ratios for METC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.8
Shares outstanding: 53804858
Market cap (USD): 634897324.4000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for METC — annual report dated 2022-12-31
Total revenue: 565688000
Gross profit: 232728000
Operating income: 150387000
Net income: 116042000
Capital expenditures: 2000000
Operating cash flow: 187870000
Depreciation & amortization: 41194000
Net tangible assets: 309198000
Owner earnings: 155236000
Return on net tangible assets (%): 50.20601685651266
Capex to operating income (%): 1.3299021856942423
Buffett classification: The Great
Stock price: 7.91
P/E ratio: 3.6676067870253872
Shares outstanding: 53804858
Book value: 309198000
P/B ratio: 1.3764527156708646
Market cap (USD): 425596426.78000003
Debt to equity: 0.4466781803245817
Current ratio: 0.905701740919279
Quick ratio: 0.6295311492523565
Effective tax rate (%): 20.625192380040357
Interest coverage ratio: 22.021818714306633
COGS to revenue (%): 58.85930053315609
SG&A to revenue (%): 7.076692452376575
Free cash flow (dilution-adjusted): 55575000
Buyback yield (%): 0
Retained earnings: 140045000
Inventory turnover: 7.403553243056945
Receivables turnover: 13.738961480545976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.69182964470097
FCF margin (%): 9.824320119924765
Rule of 40 score: 9.824320119924765
Financial ratios for METC — annual report dated 2023-12-31
Total revenue: 693524000
Gross profit: 199731000
Operating income: 95245000
Net income: 82313000
Capital expenditures: 0
Operating cash flow: 161036000
Depreciation & amortization: 54252000
Net tangible assets: 369605000
Owner earnings: 136565000
Return on net tangible assets (%): 36.94890491200065
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.3
P/E ratio: 10.654686202665436
Shares outstanding: 53804858
Book value: 369605000
P/B ratio: 2.3728553060699937
Market cap (USD): 877019185.4000001
Debt to equity: 0.27204718550885404
Current ratio: 1.1162036873624888
Quick ratio: 0.8975798006894685
Effective tax rate (%): 21.354251263579297
Interest coverage ratio: 10.698079299112658
COGS to revenue (%): 71.20056407564843
SG&A to revenue (%): 7.0409964182926625
Free cash flow (dilution-adjusted): 65227000
Buyback yield (%): 0
Retained earnings: 91944000
Inventory turnover: 13.28722116083201
Receivables turnover: 7.159622571387278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.208429968740546
FCF margin (%): 9.405153967274384
Revenue growth (%): 22.598322750350018
Rule of 40 score: 32.0034767176244
Financial ratios for METC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.42
Shares outstanding: 53804858
Market cap (USD): 614451478.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for METC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.12
Shares outstanding: 53804858
Market cap (USD): 544505162.9599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for METC — annual report dated 2024-12-31
Total revenue: 666295000
Gross profit: 133002000
Operating income: 16636000
Net income: 11192000
Capital expenditures: 0
Operating cash flow: 112665000
Depreciation & amortization: 65615000
Net tangible assets: 362806000
Owner earnings: 76807000
Return on net tangible assets (%): 21.170267305391864
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.12
P/E ratio: 48.651283323802716
Shares outstanding: 53804858
Book value: 362806000
P/B ratio: 1.5008163121888831
Market cap (USD): 544505162.9599999
Debt to equity: 0.2819302878122192
Current ratio: 1.3692455974123567
Quick ratio: 1.0150945862057699
Effective tax rate (%): 24.986595174262735
Interest coverage ratio: 2.716968806140781
COGS to revenue (%): 80.03857150361327
SG&A to revenue (%): 7.397023840791241
Free cash flow (dilution-adjusted): 26357000
Buyback yield (%): 0
Retained earnings: 69534000
Inventory turnover: 12.299760136537664
Receivables turnover: 9.055135766899513
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0123601649953464
FCF margin (%): 3.955755333598481
Revenue growth (%): -3.926179915907741
Rule of 40 score: 0.029575417690740124
Financial ratios for METC — quarterly report dated 2025-03-31
Total revenue: 134656000
Gross profit: 20524000
Operating income: -12022000
Net income: -9457000
Capital expenditures: 20313000
Operating cash flow: 26039000
Depreciation & amortization: 17542000
Net tangible assets: 355248000
Owner earnings: -12228000
Return on net tangible assets (%): -3.442102418592082
Buffett classification: The Gruesome
Stock price: 8.23
Shares outstanding: 53804858
Book value: 355248000
P/B ratio: 1.2464925385646086
Market cap (USD): 442813981.34000003
Debt to equity: 0.35235384857902086
Current ratio: 1.3184760495653782
Quick ratio: 0.8671850499754746
Interest coverage ratio: -5.391031390134529
COGS to revenue (%): 84.75819866920152
SG&A to revenue (%): 10.843928231939163
Free cash flow (dilution-adjusted): 2365000
Buyback yield (%): 0
Retained earnings: 48389000
Inventory turnover: 2.033604760971438
Receivables turnover: 2.5834772265070414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1415313142397046
FCF margin (%): 1.7563272338403042
Rule of 40 score: 1.7563272338403042
Financial ratios for METC — quarterly report dated 2025-06-30
Total revenue: 152959000
Gross profit: 18777000
Operating income: -13844000
Net income: -13974000
Capital expenditures: 15148000
Operating cash flow: -4260000
Depreciation & amortization: 17038000
Net tangible assets: 347439000
Owner earnings: -12084000
Return on net tangible assets (%): -3.4780206021776485
Buffett classification: The Gruesome
Stock price: 13.14
Shares outstanding: 53804858
Book value: 347439000
P/B ratio: 2.034877587490178
Market cap (USD): 706995834.12
Debt to equity: 0.38661750695805597
Current ratio: 1.3614033237540317
Quick ratio: 0.8401662755850844
Interest coverage ratio: -4.912704045422285
COGS to revenue (%): 87.72416137657804
SG&A to revenue (%): 9.924881831078917
Free cash flow (dilution-adjusted): -24160000
Buyback yield (%): 0
Retained earnings: 32551000
Inventory turnover: 2.262384083628393
Receivables turnover: 2.7341937329067085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.468356574468806
FCF margin (%): -15.79508234232703
Revenue growth (%): 13.592413260456274
Rule of 40 score: -2.2026690818707557
Financial ratios for METC — quarterly report dated 2025-09-30
Total revenue: 120996000
Gross profit: 19154000
Operating income: -14482000
Net income: -13308000
Capital expenditures: 20230000
Operating cash flow: -1441000
Depreciation & amortization: 17091000
Net tangible assets: 526912000
Owner earnings: -16447000
Return on net tangible assets (%): -3.1213940847807606
Buffett classification: The Gruesome
Stock price: 33.19
Shares outstanding: 53804858
Book value: 526912000
P/B ratio: 3.389148922438661
Market cap (USD): 1785783237.02
Debt to equity: 0.2588231051864448
Current ratio: 2.9731291717164408
Quick ratio: 2.235343595680408
COGS to revenue (%): 84.16972461899567
SG&A to revenue (%): 13.341763364078151
Free cash flow (dilution-adjusted): -26402000
Buyback yield (%): 0
Retained earnings: 17091000
Inventory turnover: 1.2484615196018338
Receivables turnover: 2.7743740254975693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9594392556241533
FCF margin (%): -21.820556051439716
Revenue growth (%): -20.8964493753228
Rule of 40 score: -42.71700542676251
Financial ratios for METC — quarterly report dated 2025-12-31
Total revenue: 128007000
Gross profit: 20944000
Operating income: -15607000
Net income: -14705000
Capital expenditures: 15166000
Operating cash flow: -18369000
Depreciation & amortization: 16484000
Net tangible assets: 483566000
Owner earnings: -13387000
Return on net tangible assets (%): -2.7683914915440706
Buffett classification: The Gruesome
Stock price: 18
Shares outstanding: 53804858
Book value: 483566000
P/B ratio: 2.0028030175818814
Market cap (USD): 968487444
Debt to equity: 0.969633927943652
Current ratio: 5.457589041095891
Quick ratio: 4.661652968036529
COGS to revenue (%): 83.63839477528573
SG&A to revenue (%): 15.31634988711555
Free cash flow (dilution-adjusted): -50941000
Buyback yield (%): 0
Retained earnings: -311000
Inventory turnover: 1.2284206299122253
Receivables turnover: 2.3550612650402916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.51367173292961
FCF margin (%): -39.795479934691066
Revenue growth (%): 5.794406426658733
Rule of 40 score: -34.001073508032334
Financial ratios for METC — annual report dated 2025-12-31
Total revenue: 536618000
Gross profit: 83229000
Operating income: -55956000
Net income: -51446000
Capital expenditures: 18544000
Operating cash flow: 1969000
Depreciation & amortization: 68155000
Net tangible assets: 483566000
Owner earnings: -1835000
Return on net tangible assets (%): -0.3794725022023881
Buffett classification: The Gruesome
Stock price: 18
Shares outstanding: 53804858
Book value: 483566000
P/B ratio: 2.0028030175818814
Market cap (USD): 968487444
Debt to equity: 0.969633927943652
Current ratio: 5.457589041095891
Quick ratio: 4.661652968036529
Interest coverage ratio: -7.170169144028703
COGS to revenue (%): 84.49008419397039
SG&A to revenue (%): 12.925954776023168
Free cash flow (dilution-adjusted): -99851000
Buyback yield (%): 0
Retained earnings: -311000
Inventory turnover: 5.202099707417819
Receivables turnover: 9.872649666997829
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.426988882412331
FCF margin (%): -18.60746378242996
Revenue growth (%): -19.46240028816065
Rule of 40 score: -38.06986407059061
Financial ratios for MXF — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.76
Shares outstanding: 14420065
Market cap (USD): 169579964.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MXF — annual report dated 2022-10-31
Total revenue: 762588.3955600404
Net income: 708007.1140262361
Capital expenditures: 0
Net tangible assets: 13338603.784056509
Owner earnings: 708007.1140262361
Return on net tangible assets (%): 5.307955206470032
Buffett classification: The Gruesome
Stock price: 11.67
P/E ratio: 237.6842763528561
Shares outstanding: 14420065
Book value: 13338603.784056509
P/B ratio: 12.616174921632043
Market cap (USD): 168282158.55
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 6.996565285445726
Buyback yield (%): 0
Retained earnings: -1201788.4460141272
Receivables turnover: 6.1347597238029214
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MXF — annual report dated 2023-10-31
Total revenue: 1825560.9418282548
Net income: 1761288.6426592798
Capital expenditures: 0
Net tangible assets: 15522116.066481994
Owner earnings: 1761288.6426592798
Return on net tangible assets (%): 11.346962199712932
Buffett classification: The Gruesome
Stock price: 13.07
P/E ratio: 107.00702030613131
Shares outstanding: 14420065
Book value: 15522116.066481993
P/B ratio: 12.142046145175863
Market cap (USD): 188470249.55
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 3.4399930200181323
Buyback yield (%): 0
Retained earnings: -204780.27700831025
Receivables turnover: 15.138809509807887
Capitalized R&D asset: 0
Revenue growth (%): 139.39007627929794
Rule of 40 score: 139.39007627929794
Financial ratios for MXF — annual report dated 2024-10-31
Total revenue: -286224.25595238095
Net income: -346890.72420634923
Capital expenditures: 0
Net tangible assets: 12905835.267857144
Owner earnings: -346890.72420634923
Return on net tangible assets (%): -2.687859538005293
Buffett classification: The Gruesome
Stock price: 12.78
Shares outstanding: 14420065
Book value: 12905835.267857144
P/B ratio: 14.279465596386682
Market cap (USD): 184288430.7
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -1117872.9662698412
Receivables turnover: -337.8978157756046
Capitalized R&D asset: 0
Revenue growth (%): -115.67870178388755
Rule of 40 score: -115.67870178388755
Financial ratios for MXF — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 12905835.267857144
Buffett classification: The Gruesome
Stock price: 12.78
Shares outstanding: 14420065
Book value: 12905835.267857144
P/B ratio: 14.279465596386682
Market cap (USD): 184288430.7
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -1117872.9662698412
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MXF — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 14411019.396110544
Buffett classification: The Gruesome
Stock price: 14.61
Shares outstanding: 14420065
Book value: 14411019.396110544
P/B ratio: 14.619170501349863
Market cap (USD): 210677149.65
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 277750.9211873081
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MXF — annual report dated 2025-10-31
Total revenue: 4163889.800323799
Net income: 4101230.7609282243
Capital expenditures: 0
Net tangible assets: 17135464.166216943
Owner earnings: 4101230.7609282243
Return on net tangible assets (%): 23.934167882151204
Buffett classification: The Gruesome
Stock price: 18.77
P/E ratio: 65.9959499544817
Shares outstanding: 14420065
Book value: 17135464.166216943
P/B ratio: 15.79558145752614
Market cap (USD): 270664620.05
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 1.4653003456153322
Buyback yield (%): 0
Retained earnings: 2161440.3669724767
Receivables turnover: 3743.298952066757
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MXF — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 17135464.166216943
Buffett classification: The Gruesome
Stock price: 18.77
Shares outstanding: 14420065
Book value: 17135464.166216943
P/B ratio: 15.79558145752614
Market cap (USD): 270664620.05
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 2161440.3669724767
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NATCOPHARM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.67229328761704
Shares outstanding: 179109870
Market cap (USD): 1732403193.3469605
Buyback yield (%): 0
Retained earnings: 351655017.80298036
Capitalized R&D asset: 23328497.95595411
Rule of 40 score: 0
Financial ratios for NATCOPHARM.NS — annual report dated 2023-03-31
Total revenue: 328489646.772229
Gross profit: 237685749.08647993
Operating income: 96236297.19853838
Net income: 87125456.76004873
Capital expenditures: 14104750.3045067
Operating cash flow: 103422655.29841657
Depreciation & amortization: 19951278.92813642
Net tangible assets: 570767356.8818514
Owner earnings: 92971985.38367845
Return on net tangible assets (%): 16.28894579598805
Capex to operating income (%): 14.65637261106189
Buffett classification: The Great
Stock price: 6.715590742996347
P/E ratio: 13.805707650566196
Shares outstanding: 179109870
Book value: 593641900.1218027
P/B ratio: 2.026185457435677
Market cap (USD): 1202828584.9512792
Debt to equity: 0.03613197094669457
Current ratio: 4.392182696530523
Quick ratio: 3.3046406089884357
Effective tax rate (%): 17.0089337510152
Interest coverage ratio: 83.16842105263157
COGS to revenue (%): 27.64284919722645
R&D to revenue (%): 3.344580815009826
SG&A to revenue (%): 7.5271608142682345
Free cash flow (dilution-adjusted): 78380024.36053593
Buyback yield (%): 0.0749350190669735
Retained earnings: 401010962.24116933
Inventory turnover: 1.0034997980885718
Receivables turnover: 3.1502160962504377
Capitalized R&D asset: 26616695.335726768
ROCI (R&D-adjusted, %): 15.143805213255327
FCF margin (%): 23.860728985131075
Rule of 40 score: 23.860728985131075
Financial ratios for NATCOPHARM.NS — annual report dated 2024-03-31
Total revenue: 479529919.65463483
Gross profit: 373701882.7197506
Operating income: 189087420.55402327
Net income: 166482791.70164287
Capital expenditures: 40460486.868929125
Operating cash flow: 145293200.62357596
Depreciation & amortization: 22400767.47811488
Net tangible assets: 678738457.8486629
Owner earnings: 148423072.31082863
Return on net tangible assets (%): 21.867491166077738
Capex to operating income (%): 21.397767630644342
Buffett classification: The Great
Stock price: 11.300983685220729
P/E ratio: 12.158119755460776
Shares outstanding: 179109870
Book value: 701894711.5961146
P/B ratio: 2.883791094720096
Market cap (USD): 2024117718.7320056
Debt to equity: 0.06341938459961388
Current ratio: 4.135999177631579
Quick ratio: 3.415912828947368
Effective tax rate (%): 17.042127278159548
Interest coverage ratio: 131.4
COGS to revenue (%): 21.56897069120736
R&D to revenue (%): 3.5435630689206765
SG&A to revenue (%): 6.7095128538561575
Free cash flow (dilution-adjusted): 102278450.65355559
Buyback yield (%): 1.5030406515485675
Retained earnings: 535519846.504377
Inventory turnover: 1.2312633832976445
Receivables turnover: 3.3634452014467153
Capitalized R&D asset: 32051872.605280623
ROCI (R&D-adjusted, %): 25.41425408122846
Rosenberg metric: 12.380182451542705
FCF margin (%): 21.328898669600882
Revenue growth (%): 45.98022323276917
Rule of 40 score: 67.30912190237005
Financial ratios for NATCOPHARM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 825645007.1667463
Buffett classification: The Gruesome
Stock price: 16.815575728619205
Shares outstanding: 179109870
Book value: 854849498.3277593
P/B ratio: 3.5232348952883963
Market cap (USD): 3011835582.7281413
Debt to equity: 0.02911915940084954
Current ratio: 4.958362248438584
Quick ratio: 4.190443144641618
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NATCOPHARM.NS — quarterly report dated 2025-03-31
Total revenue: 142740238.48491934
Gross profit: 113607668.92681785
Operating income: 52583586.62613981
Net income: 47533317.7460837
Capital expenditures: 0
Depreciation & amortization: 11491699.789572129
Net tangible assets: 858183306.0556464
Owner earnings: 59025017.53565583
Return on net tangible assets (%): 6.877903254369356
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.267475784805695
P/E ratio: 8.730173180376495
Shares outstanding: 179109870
Book value: 889911152.6771101
P/B ratio: 1.865238319635896
Market cap (USD): 1659896383.044696
Debt to equity: 0.03670375576369823
Current ratio: 5.585585585585586
Quick ratio: 4.773926868044516
Effective tax rate (%): 19.7469855702708
Interest coverage ratio: 44.09803921568628
COGS to revenue (%): 20.40950040950041
Buyback yield (%): 0
Retained earnings: 730254851.5314472
Inventory turnover: 0.32541133455210236
Receivables turnover: 0.9794641424675118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.851209137148283
Rule of 40 score: 0
Financial ratios for NATCOPHARM.NS — annual report dated 2025-03-31
Total revenue: 517827916.76408696
Gross profit: 437187280.80430204
Operating income: 229226093.05588028
Net income: 220411503.39022678
Capital expenditures: 35784428.337619826
Operating cash flow: 198363338.7888707
Depreciation & amortization: 27495908.346972175
Net tangible assets: 858183306.0556464
Owner earnings: 212122983.3995791
Return on net tangible assets (%): 24.71767766895067
Capex to operating income (%): 15.610975112199101
Buffett classification: The Great
Stock price: 9.267475784805695
P/E ratio: 7.530897242263886
Shares outstanding: 179109870
Book value: 889911152.6771101
P/B ratio: 1.865238319635896
Market cap (USD): 1659896383.044696
Debt to equity: 0.03670375576369823
Current ratio: 5.585585585585586
Quick ratio: 4.773926868044516
Effective tax rate (%): 17.805708300602248
Interest coverage ratio: 82.0418410041841
COGS to revenue (%): 15.572863754374083
R&D to revenue (%): 2.5601083643752114
SG&A to revenue (%): 7.027881250705498
Free cash flow (dilution-adjusted): 138555061.95931727
Buyback yield (%): 0
Retained earnings: 730254851.5314472
Inventory turnover: 0.9007573779054584
Receivables turnover: 3.553264880474892
Capitalized R&D asset: 28267472.61487112
ROCI (R&D-adjusted, %): 24.676475524196515
Rosenberg metric: 3.7360955160696867
FCF margin (%): 26.75697031267637
Revenue growth (%): 7.986570918668634
Rule of 40 score: 34.743541231345006
Financial ratios for NATCOPHARM.NS — quarterly report dated 2025-06-30
Total revenue: 155499648.95857713
Gross profit: 128235431.78095016
Operating income: 60074888.836882755
Net income: 56248537.32740464
Capital expenditures: 0
Depreciation & amortization: 6739995.319447695
Owner earnings: 62988532.64685234
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.780482096887432
P/E ratio: 8.58195981022467
Shares outstanding: 179109870
Market cap (USD): 1930890746.9108355
Effective tax rate (%): 16.016786151425073
Interest coverage ratio: 160.4375
COGS to revenue (%): 17.533298216570095
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.938902308899976
Rule of 40 score: 8.938902308899976
Financial ratios for NATCOPHARM.NS — quarterly report dated 2025-09-30
Total revenue: 153664036.0766629
Gross profit: 134532130.77790305
Operating income: 59391206.313416004
Net income: 58444193.91206313
Capital expenditures: 0
Depreciation & amortization: 5907553.551296505
Net tangible assets: 945839909.8083427
Owner earnings: 64351747.46335963
Return on net tangible assets (%): 6.803661676361209
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.937655016910936
P/E ratio: 9.867849449543959
Shares outstanding: 179109870
Book value: 975670800.4509584
P/B ratio: 1.6407401220205218
Market cap (USD): 1600822228.1837656
Debt to equity: 0.030124101592290446
Current ratio: 4.098058823529412
Quick ratio: 3.6168823529411767
Effective tax rate (%): 15.61023301287274
Interest coverage ratio: 40.213740458015266
COGS to revenue (%): 12.450476889214967
Buyback yield (%): 0
Inventory turnover: 0.2074572127139364
Receivables turnover: 0.7929489789981965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.0342951398036675
Revenue growth (%): -1.1804611098531863
Rule of 40 score: -1.1804611098531863
Financial ratios for NATCOPHARM.NS — quarterly report dated 2025-12-31
Total revenue: 72106494.37451264
Gross profit: 57279714.82677955
Operating income: 12532026.28940626
Net income: 16876462.069733765
Capital expenditures: 0
Depreciation & amortization: 5146485.462849504
Owner earnings: 22022947.53258327
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.042553191489361
P/E ratio: 10.042965818834984
Shares outstanding: 179109870
Market cap (USD): 1798720396.5957446
Effective tax rate (%): 12.849162011173185
Interest coverage ratio: 11.842105263157894
COGS to revenue (%): 20.562335856635254
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -53.07523073353432
Rule of 40 score: -53.07523073353432
Financial ratios for NEN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.03
Shares outstanding: 2816879
Market cap (USD): 157829730.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEN — annual report dated 2022-12-31
Total revenue: 68293726
Gross profit: 45156786
Operating income: 18088147
Net income: 3723274
Capital expenditures: 0
Operating cash flow: 21539727
Depreciation & amortization: 16373429
Net tangible assets: 0
Owner earnings: 20096703
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 60.65
P/E ratio: 45.88534482017708
Shares outstanding: 2816879
Book value: -59869357
Market cap (USD): 170843711.35
Debt to equity: -6.864383043231949
Current ratio: 4.451309996087831
Quick ratio: 4.451309996087831
Interest coverage ratio: 1.202231541080419
COGS to revenue (%): 33.878573267477016
SG&A to revenue (%): 4.9353274413523724
Free cash flow (dilution-adjusted): 21539727
Buyback yield (%): 3.118038678688538
Receivables turnover: 26.27193061418876
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.022679596559039
FCF margin (%): 31.53983280982502
Rule of 40 score: 31.53983280982502
Financial ratios for NEN — annual report dated 2023-12-31
Total revenue: 74481368
Gross profit: 48213009
Operating income: 19785956
Net income: 8453950
Capital expenditures: 0
Operating cash flow: 24181904
Depreciation & amortization: 16773045
Net tangible assets: -1549000
Owner earnings: 25226995
Return on net tangible assets (%): -1628.598773402195
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 61.92
P/E ratio: 20.631911435482824
Shares outstanding: 2816879
Book value: -65354384
Market cap (USD): 174421147.68
Debt to equity: -6.252989730574157
Current ratio: 3.2723270505223976
Quick ratio: 3.2723270505223976
Interest coverage ratio: 1.2583497824594199
COGS to revenue (%): 35.268362686356674
SG&A to revenue (%): 5.243053537899573
Free cash flow (dilution-adjusted): 24181904
Buyback yield (%): 2.250607252740902
Receivables turnover: 23.396328025069547
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.600282896148614
FCF margin (%): 32.46705135705886
Revenue growth (%): 9.06033740200381
Rule of 40 score: 41.52738875906267
Financial ratios for NEN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.66
Shares outstanding: 2816879
Market cap (USD): 215941944.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEN — annual report dated 2024-12-31
Total revenue: 80532550
Gross profit: 54239643
Operating income: 25371253
Net income: 15661587
Capital expenditures: 0
Operating cash flow: 31934479
Depreciation & amortization: 16983336
Net tangible assets: -334000
Owner earnings: 32644923
Return on net tangible assets (%): -9773.929041916168
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 76.77
P/E ratio: 13.807783389384484
Shares outstanding: 2816879
Book value: -62433902
Market cap (USD): 216251800.82999998
Debt to equity: -6.50617528278146
Current ratio: 3.0228650021449615
Quick ratio: 3.0228650021449615
Interest coverage ratio: 1.6413741058042062
COGS to revenue (%): 32.64879480408853
SG&A to revenue (%): 5.071837412325824
Free cash flow (dilution-adjusted): 31934479
Buyback yield (%): 0.7718460579720853
Receivables turnover: 21.088256258323877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.042761343389929
FCF margin (%): 39.65412618872742
Revenue growth (%): 8.124423815631314
Rule of 40 score: 47.778550004358735
Financial ratios for NEN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.77
Shares outstanding: 2816879
Market cap (USD): 216251800.82999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEN — quarterly report dated 2025-03-31
Total revenue: 20688894
Gross profit: 14316399
Operating income: 6233447
Net income: 3795719
Capital expenditures: 0
Operating cash flow: 5477629
Depreciation & amortization: 3904983
Net tangible assets: -8284247
Owner earnings: 7700702
Return on net tangible assets (%): -92.95596811635384
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 79.07
P/E ratio: 14.669857181867254
Shares outstanding: 2816879
Book value: -71377784
Market cap (USD): 222730622.52999997
Debt to equity: -5.680820505719258
Current ratio: 2.2619547207111568
Quick ratio: 2.2619547207111568
Interest coverage ratio: 1.6440877747510703
COGS to revenue (%): 30.801525688130067
SG&A to revenue (%): 4.348202470368885
Free cash flow (dilution-adjusted): 5477629
Buyback yield (%): 0.00406455111433123
Receivables turnover: 5.70464988286782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8103987890383935
FCF margin (%): 26.47618089202835
Rule of 40 score: 26.47618089202835
Financial ratios for NEN — quarterly report dated 2025-06-30
Total revenue: 21240108
Gross profit: 14166582
Operating income: 7063573
Net income: 4149881
Capital expenditures: 0
Operating cash flow: 12530743
Depreciation & amortization: 4474748
Net tangible assets: -13516193
Owner earnings: 8624629
Return on net tangible assets (%): -63.80960230443588
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 71.27
P/E ratio: 25.266684244109943
Shares outstanding: 2816879
Book value: -68973338
Market cap (USD): 200758966.32999998
Debt to equity: -7.411197135333656
Current ratio: 0.5107207766181366
Quick ratio: 0.5107207766181366
Interest coverage ratio: 1.7077627149459547
COGS to revenue (%): 33.30268847973843
SG&A to revenue (%): 4.350782962120531
Free cash flow (dilution-adjusted): 12530743
Buyback yield (%): 0.14054913967637583
Receivables turnover: 5.545756303892323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5537258413745962
FCF margin (%): 58.995665182116774
Revenue growth (%): 2.66429901956093
Rule of 40 score: 61.6599642016777
Financial ratios for NEN — quarterly report dated 2025-09-30
Total revenue: 23686671
Gross profit: 15079681
Operating income: 4744301
Net income: -521828
Capital expenditures: 0
Operating cash flow: 2347129
Depreciation & amortization: 7374701
Net tangible assets: -13021919
Owner earnings: 6852873
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 70.1
P/E ratio: 26.598771877692364
Shares outstanding: 2816879
Book value: -71041111
Market cap (USD): 197463217.89999998
Debt to equity: -7.196496363915255
Current ratio: 0.4225844404368553
Quick ratio: 0.4225844404368553
Interest coverage ratio: 0.8705291193149238
COGS to revenue (%): 36.336849530269575
SG&A to revenue (%): 5.73889002806684
Free cash flow (dilution-adjusted): 2347129
Buyback yield (%): 0.0543154320792622
Receivables turnover: 5.89744987210022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.050323902639283
FCF margin (%): 9.90907080188685
Revenue growth (%): 11.518599622939771
Rule of 40 score: 21.427670424826623
Financial ratios for NEN — quarterly report dated 2025-12-31
Total revenue: 23580871
Gross profit: 15596477
Operating income: 3707713
Net income: -1392515
Capital expenditures: 0
Operating cash flow: 7300479
Depreciation & amortization: 7508627
Net tangible assets: -2692000
Owner earnings: 6116112
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.63
P/E ratio: 29.71818491070767
Shares outstanding: 2816879
Book value: -74215581
Market cap (USD): 179238010.77
Debt to equity: -7.108976523406857
Current ratio: 1.221052903351515
Quick ratio: 1.221052903351515
Interest coverage ratio: 0.7117502983612543
COGS to revenue (%): 33.85962291214773
SG&A to revenue (%): 5.528523522307552
Free cash flow (dilution-adjusted): 7300479
Buyback yield (%): 0.2358400420669877
Receivables turnover: 5.25684959143883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7817980953666981
FCF margin (%): 30.959327159713478
Revenue growth (%): -0.44666470860341667
Rule of 40 score: 30.51266245111006
Financial ratios for NEN — annual report dated 2025-12-31
Total revenue: 89196544
Gross profit: 59159138
Operating income: 21749034
Net income: 6031256
Capital expenditures: 0
Operating cash flow: 27655980
Depreciation & amortization: 23263058
Net tangible assets: -2692000
Owner earnings: 29294314
Return on net tangible assets (%): -1088.1988855869242
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.63
P/E ratio: 29.718189838070213
Shares outstanding: 2816879
Book value: -74215581
Market cap (USD): 179238010.77
Debt to equity: -7.108976523406857
Current ratio: 1.221052903351515
Quick ratio: 1.221052903351515
Interest coverage ratio: 1.1701344536133258
COGS to revenue (%): 33.675526710990056
SG&A to revenue (%): 5.0301635005051315
Free cash flow (dilution-adjusted): 27655980
Buyback yield (%): 0.4581539353579158
Receivables turnover: 19.88445701959676
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.585941079383857
FCF margin (%): 31.005663179057702
Revenue growth (%): 10.758375340157489
Rule of 40 score: 41.76403851921519
Financial ratios for NRZ.AX — annual report dated 2021-06-30
Operating income: -6697608.270676691
Net income: -10206145.112781955
Capital expenditures: 83102.25563909774
Depreciation & amortization: 135136.84210526315
Net tangible assets: 38573484.96240601
Owner earnings: -10154110.52631579
Return on net tangible assets (%): -26.324068297723315
Buffett classification: The Gruesome
Stock price: 0.11278195488721804
Shares outstanding: 3402758410
Book value: 38573484.96240602
P/B ratio: 9.949055571793588
Market cap (USD): 383769745.4887218
Debt to equity: 0.004382631842142528
Current ratio: 6.1642548472814624
Quick ratio: 6.1642548472814624
Interest coverage ratio: -1.8910366691943272
Free cash flow (dilution-adjusted): -6218494.736842105
Buyback yield (%): 0.27681894701422544
Retained earnings: -48545227.06766917
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.327734060952142
Rule of 40 score: 0
Financial ratios for NRZ.AX — annual report dated 2022-06-30
Operating income: -8586988.27586207
Net income: -14067694.48275862
Capital expenditures: 117693.79310344828
Depreciation & amortization: 109327.58620689655
Net tangible assets: 38956994.48275862
Owner earnings: -14076060.689655174
Return on net tangible assets (%): -36.132306602566274
Buffett classification: The Gruesome
Stock price: 0.12413793103448276
Shares outstanding: 3402758410
Book value: 38956994.48275862
P/B ratio: 10.843017908235575
Market cap (USD): 422411388.8275862
Debt to equity: 0.005696254766662061
Current ratio: 0.46882555252070046
Quick ratio: 0.46882555252070046
Interest coverage ratio: -1.5670301929801425
Free cash flow (dilution-adjusted): -11360525.51724138
Buyback yield (%): 0.03712886438962782
Retained earnings: -58595385.51724138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.715844159586016
Rule of 40 score: 0
Financial ratios for NRZ.AX — annual report dated 2023-06-30
Operating income: -8995401.324503312
Net income: -10769626.490066225
Capital expenditures: 107101.32450331126
Depreciation & amortization: 30056.953642384105
Net tangible assets: 48181331.12582781
Owner earnings: -10846670.860927153
Return on net tangible assets (%): -22.51218595974562
Buffett classification: The Gruesome
Stock price: 0.039735099337748346
Shares outstanding: 3402758410
Book value: 48181331.12582781
P/B ratio: 2.806251722074762
Market cap (USD): 135208943.44370863
Debt to equity: 0.033574090484058496
Current ratio: 0.02600717566934912
Quick ratio: 0.02600717566934912
Interest coverage ratio: -3.707133562152296
Free cash flow (dilution-adjusted): -22727821.854304634
Buyback yield (%): 0.14884884721118552
Retained earnings: -67036718.543046355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.456543877687444
Rule of 40 score: 0
Financial ratios for NSE.AS — annual report dated 2021-12-31
Gross profit: 0
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05681818181818182
Shares outstanding: 162730097
Market cap (USD): 9246028.238636365
Buyback yield (%): 0
Retained earnings: -100000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NSE.AS — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -92553.1914893617
Net income: -97872.34042553192
Capital expenditures: 0
Operating cash flow: -27659.57446808511
Net tangible assets: -205319.1489361702
Owner earnings: -97872.34042553192
Buffett classification: The Gruesome
Stock price: 0.06382978723404255
Shares outstanding: 162730097
Book value: -205319.1489361702
Market cap (USD): 10387027.468085106
Debt to equity: -0.40932642487046633
Current ratio: 0.1678832116788321
Quick ratio: 0.1678832116788321
Interest coverage ratio: -17.4
Free cash flow (dilution-adjusted): -27659.57446808511
Buyback yield (%): 0
Retained earnings: -97872.34042553192
Capitalized R&D asset: 0
Rule of 40 score: 0